Aristeia Capital LLC Effector Therapeutics Inc Transaction History

Aristeia Capital LLC

$2.93 Billion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 14, 2024	SELL	$0.0 - $0.16 $0 - $4,768	-29,800 Reduced 2.23%	1,303,646 $0
Q1 2024 May 15, 2024	SELL	$0.07 - $0.18 $11,182 - $28,754	-159,746 Reduced 10.7%	1,333,446 $186,000
Q4 2023 Feb 14, 2024	SELL	$0.07 - $0.19 $7 - $19	-100 Reduced 0.01%	1,493,192 $223,000
Q3 2023 Nov 14, 2023	SELL	$0.06 - $0.21 $264 - $924	-4,403 Reduced 0.29%	1,493,292 $119,000
Q2 2023 Aug 14, 2023	SELL	$0.1 - $0.21 $4,260 - $8,946	-42,602 Reduced 2.77%	1,497,695 $254,000
Q4 2022 Feb 14, 2023	SELL	$0.05 - $0.27 $858 - $4,637	-17,177 Reduced 1.1%	1,540,297 $246,000
Q3 2022 Nov 14, 2022	SELL	$0.08 - $0.28 $4,529 - $15,851	-56,613 Reduced 3.51%	1,557,474 $264,000
Q1 2022 May 16, 2022	SELL	$0.26 - $0.9 $30,643 - $106,073	-117,859 Reduced 6.81%	1,614,087 $634,000
Q4 2021 Feb 14, 2022	SELL	$0.7 - $1.77 $12,637 - $31,955	-18,054 Reduced 1.03%	1,731,946 $1.54 Million
Q3 2021 Nov 15, 2021	BUY	$0.57 - $2.25 $997,499 - $3.94 Million	1,750,000 New	1,750,000 $2.84 Million

Others Institutions Holding EFTRW

# of Institutions

3

Shares Held

60.1K

Call Options Held

0

Put Options Held

0

About EFFECTOR THERAPEUTICS INC

Ticker EFTRW

More about EFTRW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristeia Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristeia Capital LLC with notifications on news.